Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
4
33%
Ph phase_3
3
25%
Ph phase_2
5
42%

Phase Distribution

4

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
4(33.3%)
Phase 2Efficacy & side effects
5(41.7%)
Phase 3Large-scale testing
3(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(9)
Terminated(1)
Other(2)

Detailed Status

Completed9
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
90.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (33.3%)
Phase 25 (41.7%)
Phase 33 (25.0%)

Trials by Status

unknown217%
completed975%
terminated18%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_2

Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

NCT00006050
completedphase_1

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

NCT00030082
completedphase_1

Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

NCT00020007
completedphase_3

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

NCT00002641
unknownphase_3

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

NCT00002692
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT00006050Phase 2

Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Completed
NCT00030082Phase 1

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Completed
NCT00020007Phase 1

Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Completed
NCT00002641Phase 3

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Completed
NCT00002692Phase 3

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Unknown
NCT00003842Phase 1

IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma

Unknown
NCT00096083Phase 2

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Completed
NCT00006268Phase 1

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Completed
NCT00103298Phase 2

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Completed
NCT00110123Phase 3

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

Terminated
NCT00089401Phase 2

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Completed
NCT00019786Phase 2

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12